Pioneering Canadian HIV/AIDS researcher Mark Wainberg dies in Florida

Mark Wainberg, a Canadian researcher who helped revolutionize the world’s understanding of HIV-AIDS at a scientific, medical and political level, has died unexpectedly.

He is believed to have drowned on Tuesday afternoon while on holiday with his family in Miami.

“Canada and the world have lost a great scientist and a great man,” Dr. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS, said in an interview.

Dr. Wainberg, 71, was director of the McGill University AIDS Centre and a former president of the International AIDS Society.

A virologist, he became interested in AIDS in the 1980s during the early years of the pandemic.

Dr. Wainberg identified 3TC (Lamivudine) as an antiviral, and it became one of the first effective treatments for people who contracted HIV. Later, he also published some of the earliest research on the effectiveness of antiretroviral cocktails.

However, Dr. Wainberg did not limit himself to laboratory work. He became an outspoken advocate for human rights, from denouncing the criminalization of HIV-AIDS, through to demanding that treatment be more available and affordable, especially in the developing world.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below